Maryam Khalkhali, Somayeh Sadighian, Kobra Rostamizadeh*, Farhad Khoeini, Mehran Naghibi, Nahid Bayat, Mina Habibizadeh, Mehrdad Hamidi
|
Cécilia Delattre*, Diego Velazquez, Caroline Roques, Graciela Pavon-Djavid, Véronique Ollivier, Anna Lokajczyk, Thierry Avramoglou, Virginie Gueguen, Liliane Louedec, Giuseppina Caligiuri, Martine Jandrot-Perrus, Catherine Boisson-Vidal, Didier Letourneur, Anne Meddahi-Pelle
Schematic illustration of the subsequent steps for the stents coating process and the evaluation of their biocompatibility: in vitro, ex vivo and in vivo (abdominal aorta stenting and stent restenosis preclinical models) evaluation of Dex-PBMA.
|
Tatiana Matvienko, Viktoriya Sokolova, Svitlana Prylutska, Yuliia Harahuts, Nataliya Kutsevol, Viktor Kostjukov, Maxim Evstigneev*  , Yuriy Prylutskyy*, Matthias Epple, Uwe Ritter
It was found that the Dextran-PNIPAM+Dox nanofluid in contrast to Dox alone showed higher toxicity towards HeLa cells, whereas the SWCNT+Dox and GO+Dox nanofluids protected cells from Dox.
|